Technical Analysis for RVNC - Revance Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 11.61 -2.68% -0.32
RVNC closed down 2.68 percent on Friday, May 24, 2019, on 64 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Down
See historical RVNC trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
NR7 Range Contraction -2.68%
Lower Bollinger Band Walk Weakness -2.68%
Lower Bollinger Band Walk Weakness -2.35%
Lower Bollinger Band Touch Weakness -2.35%
New 52 Week Closing Low Bearish -0.43%
Lower Bollinger Band Walk Weakness -0.43%
Below Lower BB Weakness -0.43%

Older signals for RVNC ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Revance Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic applications worldwide. Its lead product candidate is RT001, a topical gel formulation of botulinum toxin type A, which is in Phase III clinical trials for the treatment of crow's feet lines; has completed initial Phase II clinical trials for the treatment of hyperhidrosis and for the prevention of migraine headache; and has completed Phase I clinical trials for the treatment of other indications, such as neuropathic pain and rhinitis. The company is also developing RT002, a novel injectable formulation of botulinum toxin type A, which is being tested in the four-cohort Phase I/II clinical dose escalation trials for the treatment of glabellar lines. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is based in Newark, California.
Biopharmaceutical Pain Drugs Migraine Plastic Surgery Toxins Botulinum Toxin Botulism Hyperhidrosis Neurotoxins Prevention Of Migraine Rhinitis
Is RVNC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.45
52 Week Low 10.51
Average Volume 358,207
200-Day Moving Average 19.67
50-Day Moving Average 13.8998
20-Day Moving Average 12.5945
10-Day Moving Average 12.079
Average True Range 0.6012
ADX 56.79
+DI 8.886
-DI 34.333
Chandelier Exit (Long, 3 ATRs ) 11.9364
Chandelier Exit (Short, 3 ATRs ) 12.3136
Upper Bollinger Band 13.8404
Lower Bollinger Band 11.3486
Percent B (%b) 0.1
BandWidth 19.784827
MACD Line -0.6272
MACD Signal Line -0.6109
MACD Histogram -0.0163
Fundamentals Value
Market Cap 357.81 Million
Num Shares 30.8 Million
EPS -3.44
Price-to-Earnings (P/E) Ratio -3.38
Price-to-Sales 2609.34
Price-to-Book 4.85
PEG Ratio -0.61
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.51
Resistance 3 (R3) 12.59 12.36 12.36
Resistance 2 (R2) 12.36 12.13 12.33 12.31
Resistance 1 (R1) 11.99 11.99 11.88 11.91 12.26
Pivot Point 11.76 11.76 11.71 11.73 11.76
Support 1 (S1) 11.39 11.53 11.28 11.31 10.96
Support 2 (S2) 11.16 11.39 11.13 10.91
Support 3 (S3) 10.79 11.16 10.86
Support 4 (S4) 10.71